Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Preferred Shares (2023 - 2025)

Lucid Diagnostics (LUCD) has disclosed Preferred Shares for 3 consecutive years, with $54.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Preferred Shares fell 2.94% year-over-year to $54.3 million, compared with a TTM value of $54.3 million through Sep 2025, down 2.94%, and an annual FY2024 reading of $54.4 million, up 192.18% over the prior year.
  • Preferred Shares was $54.3 million for Q3 2025 at Lucid Diagnostics, roughly flat from $54.4 million in the prior quarter.
  • Across five years, Preferred Shares topped out at $55.9 million in Q2 2024 and bottomed at $13.6 million in Q1 2023.
  • Average Preferred Shares over 3 years is $39.4 million, with a median of $54.3 million recorded in 2025.
  • The sharpest move saw Preferred Shares skyrocketed 310.41% in 2024, then dropped 2.94% in 2025.
  • Year by year, Preferred Shares stood at $18.6 million in 2023, then soared by 192.18% to $54.4 million in 2024, then dropped by 0.27% to $54.3 million in 2025.
  • Business Quant data shows Preferred Shares for LUCD at $54.3 million in Q3 2025, $54.4 million in Q2 2025, and $54.4 million in Q1 2025.